Paper · 36964133
Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review.
Ruze R and 6 others. Signal Transduct Target Ther, 2023. Cited by 86 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review. Papers, record 36964133. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36964133
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus | Major topic |
| Pancreatic Neoplasms | Major topic |
| Humans | |
| Carcinogenesis | |
| Obesity | |
| Pancreas | |
| Tumor Microenvironment |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References541
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,638,645 | Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease. | Endocrinology | 2020 | https://conductscience.org/library/papers/31638645 | PubMed |
| 2 | 29,693,005 | Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/29693005 | PubMed |
| 3 | 23,934,186 | The Yin and Yang of Toll-like receptors in cancer. | Oncogene | 2014 | https://conductscience.org/library/papers/23934186 | PubMed |
| 4 | 23,671,428 | Biochemistry of adipose tissue: an endocrine organ. | Arch Med Sci | 2013 | https://conductscience.org/library/papers/23671428 | PubMed |
| 5 | 30,856,230 | Nicotinamide phosphoribosyltransferase expression and clinical outcome of resected stage I/II pancreatic ductal adenocarcinoma. | PLoS One | 2019 | https://conductscience.org/library/papers/30856230 | PubMed |
| 6 | 24,378,801 | Therapeutic opportunities of the IL-22-IL-22R1 system. | Nat Rev Drug Discov | 2014 | https://conductscience.org/library/papers/24378801 | PubMed |
| 7 | 21,779,469 | Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer. | Genes Cancer | 2010 | https://conductscience.org/library/papers/21779469 | PubMed |
| 8 | 34,066,392 | Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34066392 | PubMed |
| 9 | 25,356,037 | SIBLINGs and SPARC families: their emerging roles in pancreatic cancer. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25356037 | PubMed |
| 10 | 26,715,642 | Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia. | Cancer Discov | 2016 | https://conductscience.org/library/papers/26715642 | PubMed |
1 to 10 of 541
See all 541 referencesCited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,958,510 | Association between a combined lifestyle exposure index and age at pancreatic cancer diagnosis: a hospital-based retrospective study. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42958510 | PubMed |
| 42,724,341 | Metabolic reprogramming in diabetes and cancer: the role of PI3K/AKT/mTOR and beyond. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42724341 | PubMed |
| 42,699,280 | Microbiome-based diagnostic biomarkers in pancreatic ductal adenocarcinoma: Current evidence and translational challenges (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/42699280 | PubMed |
| 42,683,279 | Performance of risk prediction models for pancreatic cancer in patients with new-onset diabetes: a systematic review and meta-analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42683279 | PubMed |
| 42,680,727 | Immune checkpoints and immunoregulation in metabolic diseases and cancers: pathological mechanisms and therapeutic potential. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42680727 | PubMed |
| 42,668,993 | Survival rate in patients with pancreatic cancer in Guilan province, Iran. | Caspian J Intern Med | 2026 | https://conductscience.org/library/papers/42668993 | PubMed |
| 42,640,901 | Burden of early-onset pancreatic cancer and its association with risk factors in women of childbearing age. | PLoS One | 2026 | https://conductscience.org/library/papers/42640901 | PubMed |
| 42,625,611 | Distinct prognostic impact of diabetes subtypes, metformin use, and glycemic control in pancreatic cancer: a systematic review and meta-analysis of cohort studies. | Front Oncol | 2026 | https://conductscience.org/library/papers/42625611 | PubMed |
| 42,549,759 | Cardiovascular-Kidney-Metabolic Syndrome Severity and Risk of Pancreatic Cancer in a Large Prospective Cohort. | Diabetes Metab Res Rev | 2026 | https://conductscience.org/library/papers/42549759 | PubMed |
| 42,511,782 | Integrating Network Toxicology with Molecular Dynamics Simulations to Reveal Key Targets and Binding Mechanisms of Bisphenol A in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511782 | PubMed |
1 to 10 of 64
See all 64 cited byGenes249
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACACA | 31 | PubTator's text mining | https://conductscience.org/library/genes/31 | NCBI Gene |
| ACAT1 | 38 | PubTator's text mining | https://conductscience.org/library/genes/38 | NCBI Gene |
| ACKR1 | 2,532 | PubTator's text mining | https://conductscience.org/library/genes/2532 | NCBI Gene |
| ACLY | 47 | PubTator's text mining | https://conductscience.org/library/genes/47 | NCBI Gene |
| ACTA1 | 58 | PubTator's text mining | https://conductscience.org/library/genes/58 | NCBI Gene |
| ADAM10 | 102 | PubTator's text mining | https://conductscience.org/library/genes/102 | NCBI Gene |
| ADIPOQ | 9,370 | PubTator's text mining | https://conductscience.org/library/genes/9370 | NCBI Gene |
| AGER | 177 | PubTator's text mining | https://conductscience.org/library/genes/177 | NCBI Gene |
| AGR2 | 10,551 | PubTator's text mining | https://conductscience.org/library/genes/10551 | NCBI Gene |
| AHR | 196 | PubTator's text mining | https://conductscience.org/library/genes/196 | NCBI Gene |
1 to 10 of 249
See all 249 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36964133
GET https://conductscience.org/api/papers/v1/36964133/references?page=2